ABT
Abbott Laboratories
$100.75
-0.69%
-0.73
Notify me if price changes either direction
Buy ABT stocks now with Interactive Brokers – the most advanced investment platform
Loading
Key Stats
Market cap.
183.1B
Enterprise value
192.6B
Trailing PE
33.19874
Forward PE
20.474709
PEG Ratio
20.474709
Enterprise to EBITDA
18.371
Enterprise to revenue
4.73
Price to book MRQ
4.7173786
Price to sales TTM
4.495486
Financials
Fiscal Year Ends
2023-12-31
Most Recent Quarter (MRQ)
2024-03-31
Revenue (TTM)
40.7B
EBITDA
10.4B
Diluted EPS TTM
3.17
Total Cash (MRQ)
6.7B
Current ratio (MRQ)
1.595891876471
Operating Cash Flow (TTM)
7.7B
